Technical Analysis for CABA - Cabaletta Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 13.66 | 2.55% | 0.34 |
CABA closed down 0.15 percent on Monday, April 22, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Lower Bollinger Band Walk | Weakness | 2.55% | |
| Wide Bands | Range Expansion | 2.55% | |
| Below Lower BB | Weakness | 2.55% | |
| Down 3 Days in a Row | Weakness | 2.55% | |
| Down 4 Days in a Row | Weakness | 2.55% | |
| Lower Bollinger Band Touch | Weakness | 2.55% | |
| Oversold Stochastic | Weakness | 2.55% | |
| Lower Bollinger Band Walk | Weakness | 2.40% | |
| Wide Bands | Range Expansion | 2.40% | |
| Below Lower BB | Weakness | 2.40% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 32 minutes ago |
| Rose Above Lower Bollinger Band | 32 minutes ago |
| Up 3% | 32 minutes ago |
| Up 2% | 32 minutes ago |
| Up 1% | 32 minutes ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Antibodies Autoimmune Disease Autoimmunity T Cell Sjögren Syndrome
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Antibodies Autoimmune Disease Autoimmunity T Cell Sjögren Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.35 |
| 52 Week Low | 7.69 |
| Average Volume | 965,299 |
| 200-Day Moving Average | 17.27 |
| 50-Day Moving Average | 19.58 |
| 20-Day Moving Average | 16.44 |
| 10-Day Moving Average | 15.99 |
| Average True Range | 1.17 |
| RSI (14) | 25.37 |
| ADX | 29.42 |
| +DI | 11.19 |
| -DI | 34.24 |
| Chandelier Exit (Long, 3 ATRs) | 15.54 |
| Chandelier Exit (Short, 3 ATRs) | 16.38 |
| Upper Bollinger Bands | 19.33 |
| Lower Bollinger Band | 13.54 |
| Percent B (%b) | -0.04 |
| BandWidth | 35.18 |
| MACD Line | -1.41 |
| MACD Signal Line | -1.13 |
| MACD Histogram | -0.2747 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 14.39 | ||||
| Resistance 3 (R3) | 14.36 | 13.97 | 14.21 | ||
| Resistance 2 (R2) | 13.97 | 13.70 | 13.99 | 14.15 | |
| Resistance 1 (R1) | 13.65 | 13.53 | 13.46 | 13.68 | 14.09 |
| Pivot Point | 13.26 | 13.26 | 13.17 | 13.28 | 13.26 |
| Support 1 (S1) | 12.94 | 12.99 | 12.75 | 12.97 | 12.55 |
| Support 2 (S2) | 12.55 | 12.82 | 12.57 | 12.49 | |
| Support 3 (S3) | 12.23 | 12.55 | 12.43 | ||
| Support 4 (S4) | 12.26 |
